140 related articles for article (PubMed ID: 2752141)
1. Impaired cytoplasmic ionized calcium mobilization in inherited platelet secretion defects.
Rao AK; Kowalska MA; Disa J
Blood; 1989 Aug; 74(2):664-72. PubMed ID: 2752141
[TBL] [Abstract][Full Text] [Related]
2. Platelet secretion defect associated with impaired liberation of arachidonic acid and normal myosin light chain phosphorylation.
Rao AK; Koike K; Willis J; Daniel JL; Beckett C; Hassel B; Day HJ; Smith JB; Holmsen H
Blood; 1984 Oct; 64(4):914-21. PubMed ID: 6089937
[TBL] [Abstract][Full Text] [Related]
3. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium.
Hardisty RM; Machin SJ; Nokes TJ; Rink TJ; Smith SW
Br J Haematol; 1983 Apr; 53(4):543-57. PubMed ID: 6830700
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects.
Rao AK; Willis J; Hassell B; Dangelmaier C; Holmsen H; Smith JB
Am J Hematol; 1984 Aug; 17(2):153-65. PubMed ID: 6431801
[TBL] [Abstract][Full Text] [Related]
5. Defective acid hydrolase secretion in RUNX1 haplodeficiency: Evidence for a global platelet secretory defect.
Rao AK; Poncz M
Haemophilia; 2017 Sep; 23(5):784-792. PubMed ID: 28662545
[TBL] [Abstract][Full Text] [Related]
6. Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin.
Ware JA; Johnson PC; Smith M; Salzman EW
J Clin Invest; 1986 Mar; 77(3):878-86. PubMed ID: 3081576
[TBL] [Abstract][Full Text] [Related]
7. Human platelet signaling defect characterized by impaired production of inositol-1,4,5-triphosphate and phosphatidic acid and diminished Pleckstrin phosphorylation: evidence for defective phospholipase C activation.
Yang X; Sun L; Ghosh S; Rao AK
Blood; 1996 Sep; 88(5):1676-83. PubMed ID: 8781423
[TBL] [Abstract][Full Text] [Related]
8. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
[TBL] [Abstract][Full Text] [Related]
9. Concomitant defect in internal release and influx of calcium in patients with congenital platelet dysfunction and impaired agonist-induced calcium mobilization. Thromboxane production is not required for internal release of calcium.
Rao AK; Disa J; Yang X
J Lab Clin Med; 1993 Jan; 121(1):52-63. PubMed ID: 8426081
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.
Ware JA; Johnson PC; Smith M; Salzman EW
Circ Res; 1986 Jul; 59(1):39-42. PubMed ID: 3089642
[TBL] [Abstract][Full Text] [Related]
11. Effects of dilazep on cytoplasmic calcium ion concentrations and arachidonic acid metabolism in activated human platelets.
Okuma M; Kanaji K; Sensaki S; Uchino H
Arzneimittelforschung; 1989 Mar; 39(3):372-5. PubMed ID: 2502990
[TBL] [Abstract][Full Text] [Related]
12. Platelets from bleeding Simmental cattle mobilize calcium, phosphorylate myosin light chain and bind normal numbers of fibrinogen molecules but have abnormal cytoskeletal assembly and aggregation in response to ADP.
Searcy GP; Frojmovic MM; McNicol A; Robertson C; Wong T; Gerrard JM
Thromb Haemost; 1994 Feb; 71(2):240-6. PubMed ID: 8191406
[TBL] [Abstract][Full Text] [Related]
13. Aequorin-detected calcium changes in stimulated thrombasthenic platelets. Aggregation-dependent calcium movement in response to ADP.
Lecompte T; Potevin F; Champeix P; Morel MC; Favier R; Hurtaud MF; Schlegel N; Samama M; Kaplan C
Thromb Res; 1990 Jun; 58(6):561-70. PubMed ID: 2117306
[TBL] [Abstract][Full Text] [Related]
14. Hermansky-Pudlak platelets: further studies on release reaction and protein phosphorylations.
Rendu F; Maclouf J; Launay JM; Boinot C; Levy-Toledano S; Tanzer J; Caen J
Am J Hematol; 1987 Jun; 25(2):165-74. PubMed ID: 3111247
[TBL] [Abstract][Full Text] [Related]
15. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
17. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder.
Patel YM; Patel K; Rahman S; Smith MP; Spooner G; Sumathipala R; Mitchell M; Flynn G; Aitken A; Savidge G
Blood; 2003 Jun; 101(12):4828-35. PubMed ID: 12609843
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of cytoplasmic Ca2+ in platelets from patients with uremia.
Ware JA; Clark BA; Smith M; Salzman EW
Blood; 1989 Jan; 73(1):172-6. PubMed ID: 2910357
[TBL] [Abstract][Full Text] [Related]
20. Metal ion contents of gel-filtered platelets from patients with storage pool disease.
Lages B; Scrutton MC; Holmsen H; Day HJ; Weiss HJ
Blood; 1975 Jul; 46(1):119-30. PubMed ID: 1131423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
